Epizyme Inc (NASDAQ:EPZM)
| 1.49 BATS BZX Real-Time Price As of 12:43pm ET |  -0.01 / -0.67%Today’s Change | 0.41 Today|||52-Week Range 7.79 | -40.60% Year-to-Date |
Latest EPZM News | Press Releases
| Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More Jun 29 / Zacks.com - Paid Partner Content | Why Epizyme Stock Is Soaring Today Jun 27 / MotleyFool.com - Paid Partner Content |
| Why Adaptimmune Therapeutics Stock Is Popping Today Jun 27 / MotleyFool.com - Paid Partner Content | Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen Jun 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.50 |
| Today’s open | 1.49 |
| Day’s range | 1.49 - 1.50 |
| Volume | 68,154 |
| Average volume (3 months) | 3,233,017 |
| Market cap | $250.8M |
Data as of 12:43pm ET, 07/07/2022
Growth & Valuation
| Earnings growth (last year) | -6.61% |
| Earnings growth (this year) | +43.57% |
| Earnings growth (next 5 years) | +38.00% |
| Revenue growth (last year) | +137.45% |
| P/E ratio | NM |
| Price/Sales | 6.86 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OTLKOutlook Therapeutics... | +0.01 | +0.90% |
| XOMAXOMA Corp | +1.42 | +6.32% |
| ALDXAldeyra Therapeutics... | +0.20 | +4.71% |
| RYTMRhythm Pharmaceutica... | +0.07 | +1.48% |
Data as of 12:45pm ET, 07/07/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $37.4M |
| Annual profit (last year) | -$251.1M |
| Net profit margin | -670.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
